Gender-Related Differences in Clinical Characteristics and Outcomes of Premature Coronary Artery Disease: Insight from the FOCUS Registry

Table 4

Clinical outcomes comparing male and female for 36 months.

Outcomes	Total	Male	Female	p value
(Follow-up for 1382 patients)	(n=1382)	(n=865)	(n=517)
All-cause death	17 (1.2%)	9 (1.0%)	8 (1.5%)	0.408
Cardiovascular death	10 (0.7%)	5 (0.6%)	5 (1.0%)	0.408
MI	47 (3.4%)	30 (3.5%)	17 (3.3%)	0.858
Nonfatal MI	43 (3.1%)	28 (3.2%)	15 (2.9%)	0.728
Any revascularization	75 (5.4%)	50 (5.8%)	25 (4.8%)	0.453
TVR	30 (2.2%)	17 (2.0%)	13 (2.5%)	0.498
Non-TVR	45 (3.3%)	33 (3.8%)	12 (2.3%)	0.130
MACE	83 (6.0%)	50 (5.8%)	33 (6.4%)	0.648
Definite/probable ST	9 (0.7%)	5 (0.6%)	4 (0.8%)	0.927
DAPT	147 (10.6%)	94 (10.9%)	53 (10.3%)	0.719

Values are presented as n (percentage).
DAPT: dual antiplatelet therapy; MI: myocardial infarction; MACE: major adverse cardiovascular event; ST: stent thrombosis; and TVR: target vascular revascularization.